Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Investment
    • HUL, GSK Consumer...

    HUL, GSK Consumer shares rise 4 pc after boards approve merger

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-12-05T09:57:22+05:30  |  Updated On 16 Aug 2021 1:20 PM IST

    New Delhi: Shares of Hindustan Unilever and Glaxo Smith Kline (GSK) Consumer Healthcare Monday surged 4 per cent on BSE after their boards approved the merger of the two companies.


    The stock of HUL jumped 4.12 per cent to close at Rs 1,825.90. Intra-day, it gained 4.89 per cent to hit the 52-week high of Rs 1,839.5.




    The scrip of GSK went up by 3.75 to end at Rs 7,542.85. During the trading session, it soared 5.73 per cent to Rs 7687.2.


    Anglo-Dutch FMCG giant Unilever Monday said it will acquire health food and drinks portfolio of GSK in India and over 20 other markets predominantly in Asia for a consideration of 3.1 billion pounds.


    As part of the transaction, Unilever's Indian arm Hindustan Unilever will acquire GSK Consumer Healthcare (GSK CH India) via an all-equity merger, valuing the total business of the latter at Rs 31,700 crore.


    In separate regulatory filings, HUL and GSK announced that their respective boards have approved their merger.

    BSEGlaxo Smith KlineGSK Consumer HealthcarehealthHindustan UnileverHULIndia

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok